BRAF V600E mutation in serrated lesions of the colon has been implicated as an important mutation and as a specific marker for the serrated carcinogenic pathway. Recent findings point to microvesicular hyperplastic polyps that have similar histologic and molecular features to sessile serrated adenomas/polyps, as potential colorectal carcinoma precursors. The aim of this study was to evaluate BRAF V600E mutation status by immunohistochemistry in serrated lesions of the colon with regard to histomorphology. We investigated 194 serrated lesions of the colon, comprising 42 sessile serrated adenomas/polyps, 16 traditional serrated adenomas, 136 hyperplastic polyps and 20 tubular/tubulovillous adenomas (conventional adenomas) with the novel BRAF V600E mutation-specific antibody VE1. In addition, BRAF exon 15 and KRAS exon 2 status was investigated by capillary sequencing in selected cases. All sessile serrated adenomas/polyps (42/42, 100%), 15/ 16 (94%) traditional serrated adenomas and 84/136 (62%) hyperplastic polyps were VE1 þ . None of the VE1 À serrated lesions showed BRAF V600E mutation. Forty out of 42 (95%) sessile serrated adenomas/polyps displayed areas with microvesicular hyperplastic polyp-like features. In microvesicular hyperplastic polyps, VE1 positivity was significantly associated with nuclear atypia (P ¼ 0.003); however, nuclear atypia was also present in VE1 À cases. Immunostaining with VE1 allows not only the detection of BRAF V600E mutation but also the correlation with histomorphology on a cellular level in serrated lesions. VE1 enables a subclassification of microvesicular hyperplastic polyps according to the mutation status. This improved classification of serrated lesions including immunohistochemical evaluation of BRAF V600E mutation may be the key to identify lesions with higher potential to progression into sessile serrated adenoma/polyp, and further to BRAF V600E-mutated colorectal cancer. Modern Pathology (2014) 27, 135-144; doi:10.1038/modpathol.2013; published online 26 July 2013Keywords: BRAF; colon; immunohistochemistry; morphology; serrated polyp Colorectal cancer is one of the leading causes of cancer death worldwide. Although increased use of screening and surveillance, as well as detection and the removal of conventional adenomas, has led to a reduction in the incidence and mortality of this disease, this effect is mainly limited to distal colorectal cancer. 1-5 However, difficulties remain in the prevention of proximal colorectal cancer.A recent study suggested that colorectal cancers of the proximal colon develop in a significantly shorter period of time than those in the distal colon, after a patient has had a negative colonoscopy. 2,3 Thus, there is a need for improved and targeted identification of neoplastic precursor lesions in the proximal colon.Colorectal cancer arises from several different types of precursor lesions. In the conventional pathway, carcinomas develop from adenomas via biallelic APC (adenomatous polyposis coli) mutations 6 and are reinforced by KRAS mutatio...